(Q39273438)

10 September 2017

miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells (English)

1 reference

10 September 2017

1 reference

Hai-Jiao Yan

1

1 reference

10 September 2017

Wen-Song Liu

2

1 reference

10 September 2017

Wen-Hui Sun

3

1 reference

10 September 2017

Jun Wu

4

1 reference

10 September 2017

Mei Ji

5

1 reference

10 September 2017

Qi Wang

6

1 reference

10 September 2017

Xiao Zheng

7

1 reference

10 September 2017

Jing-Ting Jiang

8

1 reference

10 September 2017

Chang-Ping Wu

9

1 reference

10 September 2017

22 September 2012

1 reference

Digestive Diseases and Sciences

10 September 2017

1 reference

10 September 2017

57

1 reference

10 September 2017

12

1 reference

10 September 2017

3160-3167

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-012-2400-4

10 September 2017

0 references

cites work

Anti-angiogenic agents in pancreatic cancer: a review

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

miR-181a and miR-630 regulate cisplatin-induced cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

c-Myc-regulated microRNAs modulate E2F1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

let-7 and miR-17-92: small-sized major players in lung cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Role of Bcl-2 family proteins and caspases in the regulation of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

BH3-only proteins in apoptosis at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Bim is a suppressor of Myc-induced mouse B cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Caspases 3 and 7: key mediators of mitochondrial events of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

The microRNA-17~92 cluster: Still a miRacle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2400-4

MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23001407

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10620-012-2400-4

1 reference

10 September 2017

1 reference